DVD kiosks up marketshare
Five years after renting its first DVD, Coinstar Inc.’s Redbox video rental kiosk business hit the half billion rental mark in August. The company, the first fully automated DVD rental provider, has 22,000 machines in a variety of retail locations and processes about 80 transactions a second on Friday nights.
Redbox and its competitors, including NCR’s Blockbuster Express and DVDPlay, now own 19% of the rental market, compared with 36% for Netflix and other rent-by-mail services, and 45% for traditional rental stores, according to data from the NPD Group.
“These kiosks are a game changer,” said Eric Handler, senior analyst for MKM Partners. “They are impacting traditional rentals, Netflix and video on demand, and it’s becoming the way the industry is evolving. And they have some interesting contracts with supermarkets and drug stores.”
For retailers and consumers, the kiosks are a win-win. Retailers view the kiosks as traffic producers, and are using coupons and special offers to induce trial. Walgreens recently ran a promotion offering a free rental from its Redbox kiosks with the purchase of two boxes of cereal. Redbox runs its own free rental coupons for Monday nights. Consumers like the convenience and the value, particularly in this tight economy. At $1 a night, the kiosks are hard to beat.
But some studios, afraid that $1 rentals will create downward pressure on the industry’s price structure and hurt profits from both DVD sales and rentals, aren’t playing ball. Universal, 20th Century Fox and Warner Bros. are refusing to sell new releases to Redbox until at least 28 days after they arrive in stores. Redbox has filed suit against the studios, citing antitrust violations, and has vowed to continue to offer consumers the latest releases even if it has to purchase the DVDs at retail prices.
Despite the legal battles, other DVD rental kiosks are moving full steam ahead into the market. NCR, which now has about 500 Blockbuster Express machines in the market, plans to add an additional 2,500 kiosks this year, and another 10,000 in 2010, according to spokesman Jeff Dudash.
Late-stage clinical trial results: MS drug is effective
ALISO VIEJO, Calif. Patients taking an investigational drug for multiple sclerosis fared better than those taking placebo, according to late-stage clinical results presented Friday at a neurology conference.
Avanir Pharmaceuticals said MS patients taking Zenvia (dextromethorphan and quinidine) in 30 mg/10 mg doses experienced a 11.9% greater reduction in pseudobulbar effect – an MS-related condition also known as PBA that causes sudden, uncontrollable episodes of laughter, crying and other emotional outbursts – than those taking placebo in a 12-week phase 3 trial, results of which the company presented at the 3rd World Congress on Controversies in Neurology in Prague, Czech Republic. Patients taking the 20 mg/10 mg dose did not do better than the placebo group.
“PBA represents an area of high, unmet medical need with no FDA-approved treatments currently available,” study presenter and trial steering committee member Daniel Wynn of the Consultants in Neurology Multiple Sclerosis Center stated. “Although the involuntary emotional outbursts of PBA cause considerable impairment for millions of individuals in the United States, it is under-recognized and commonly misdiagnosed.”
New report projects 12.6% increase of probiotics market
NEW YORK The two takeaways from this story are “the [U.S.] market is expected to grow at a rate of almost 14%” and “the early movers in the industry will benefit in terms of market share.”
That about describes the opportunity in a probiotic nutshell.
The rising interest in probiotics can be credited in part to Dannon’s Activia brand, a line of yogurts and yogurt drinks, which has been heavily advertised to the American consumer with the message that not all bacteria is bad for you — and in fact some bacteria taken on a regular basis can impart some pretty significant health benefits. That advertising message — that probiotics can be an important piece in a healthier-for-you diet — has been all the more reinforced as Bayer supports its probiotic Phillips Colon Health, and as Procter & Gamble rolls out its Align probiotic.
And the consumers already are core drug store shoppers. The ratio of women to men in search of a product delivering digestive benefits is about 2-to-1, according to industry experts. When women hit their 30s and 40s, that’s the point in their lives when they’re looking for a strategy in life to help them manage their digestive issues.